Carmat SA
PAR:ALCAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Carmat SA
Total Receivables
Carmat SA
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Carmat SA
PAR:ALCAR
|
Total Receivables
€4.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Total Receivables
€22.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Biomerieux SA
PAR:BIM
|
Total Receivables
€1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Total Receivables
€3.6m
|
CAGR 3-Years
41%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Total Receivables
€21.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Total Receivables
€3.2m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
Carmat SA
Glance View
Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.
See Also
What is Carmat SA's Total Receivables?
Total Receivables
4.3m
EUR
Based on the financial report for Dec 31, 2024, Carmat SA's Total Receivables amounts to 4.3m EUR.
What is Carmat SA's Total Receivables growth rate?
Total Receivables CAGR 10Y
3%
Over the last year, the Total Receivables growth was -17%. The average annual Total Receivables growth rates for Carmat SA have been 4% over the past three years , 8% over the past five years , and 3% over the past ten years .
